BlackRock’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-371,388
| Closed | -$3.83M | – | 5526 |
|
|
2023
Q3 | $3.83M | Sell |
371,388
-107,050
| -22% | -$1.02M | ﹤0.01% | 3767 |
|
|
2023
Q2 | $3.95M | Buy |
478,438
+14,543
| +3% | +$87K | ﹤0.01% | 3807 |
|
|
2023
Q1 | $2.59M | Sell |
463,895
-51,283
| -10% | -$294K | ﹤0.01% | 3930 |
|
|
2022
Q4 | $2.55M | Sell |
515,178
-1,969
| -0.4% | -$8.11K | ﹤0.01% | 4027 |
|
|
2022
Q3 | $2.48M | Buy |
517,147
+5,695
| +1% | +$24.4K | ﹤0.01% | 4075 |
|
|
2022
Q2 | $1.31M | Sell |
511,452
-1,167,770
| -70% | -$4.38M | ﹤0.01% | 4423 |
|
|
2022
Q1 | $9.67M | Sell |
1,679,222
-2,014,693
| -55% | -$18.1M | ﹤0.01% | 3594 |
|
|
2021
Q4 | $55.4M | Buy |
3,693,915
+197,419
| +6% | +$3.59M | ﹤0.01% | 2595 |
|
|
2021
Q3 | $91.6M | Buy |
3,496,496
+19,763
| +0.6% | +$728K | ﹤0.01% | 2275 |
|
|
2021
Q2 | $174M | Sell |
3,476,733
-58,478
| -2% | -$2.62M | ﹤0.01% | 1867 |
|
|
2021
Q1 | $163M | Buy |
3,535,211
+252,958
| +8% | +$12.1M | ﹤0.01% | 1863 |
|
|
2020
Q4 | $141M | Buy |
3,282,253
+214,080
| +7% | +$8.13M | ﹤0.01% | 1857 |
|
|
2020
Q3 | $125M | Sell |
3,068,173
-46,527
| -1% | -$2.32M | ﹤0.01% | 1740 |
|
|
2020
Q2 | $170M | Buy |
3,114,700
+172,778
| +6% | +$9.88M | 0.01% | 1481 |
|
|
2020
Q1 | $154M | Sell |
2,941,922
-93,149
| -3% | -$5.04M | 0.01% | 1352 |
|
|
2019
Q4 | $148M | Buy |
3,035,071
+109,101
| +4% | +$5.11M | 0.01% | 1716 |
|
|
2019
Q3 | $161M | Buy |
2,925,970
+173,295
| +6% | +$9.92M | 0.01% | 1572 |
|
|
2019
Q2 | $137M | Buy |
2,752,675
+105,190
| +4% | +$5.23M | 0.01% | 1694 |
|
|
2019
Q1 | $149M | Buy |
2,647,485
+46,601
| +2% | +$2.78M | 0.01% | 1624 |
|
|
2018
Q4 | $166M | Buy |
2,600,884
+40,174
| +2% | +$2.84M | 0.01% | 1450 |
|
|
2018
Q3 | $208M | Buy |
2,560,710
+441,203
| +21% | +$32.3M | 0.01% | 1474 |
|
|
2018
Q2 | $135M | Buy |
2,119,507
+484,979
| +30% | +$23.8M | 0.01% | 1736 |
|
|
2018
Q1 | $63.4M | Buy |
1,634,528
+1,209,501
| +285% | +$42.4M | ﹤0.01% | 2130 |
|
|
2017
Q4 | $11.9M | Buy |
425,027
+12,121
| +3% | +$355K | ﹤0.01% | 3058 |
|
|
2017
Q3 | $11M | Buy |
412,906
+18,295
| +5% | +$349K | ﹤0.01% | 3116 |
|
|
2017
Q2 | $5.94M | Buy |
394,611
+193,870
| +97% | +$2.62M | ﹤0.01% | 3420 |
|
|
2017
Q1 | $2.71M | Buy |
+200,741
| New | +$2.88M | ﹤0.01% | 3570 |
|
Other funds holding TRHC
BlackRock's TRHC Position: Q4 2023 in Review
BlackRock sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 371,388 shares — an estimated $3.83M sold.
BlackRock first reported a position in TRHC in Q1 2017 and held it in 27 quarters. The position peaked at $208M in Q3 2018. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.
- BlackRock reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- BlackRock sold 371,388 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $3.83M.
- BlackRock first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q1 2017 and held it in 27 quarters.
- BlackRock's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $208M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.
Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.